Free Trial

Short Interest in Pharma Mar, S.A. (OTCMKTS:PHMMF) Grows By 43.4%

Pharma Mar logo with Medical background
Remove Ads

Pharma Mar, S.A. (OTCMKTS:PHMMF - Get Free Report) was the target of a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 32,700 shares, an increase of 43.4% from the February 13th total of 22,800 shares. Approximately 0.2% of the company's stock are sold short. Based on an average trading volume of 100 shares, the short-interest ratio is currently 327.0 days.

Pharma Mar Price Performance

Shares of PHMMF stock remained flat at $102.08 on Wednesday. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.55 and a quick ratio of 2.01. Pharma Mar has a 12-month low of $26.85 and a 12-month high of $105.60. The company has a 50-day simple moving average of $93.08 and a 200-day simple moving average of $76.40.

About Pharma Mar

(Get Free Report)

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.

Read More

Should You Invest $1,000 in Pharma Mar Right Now?

Before you consider Pharma Mar, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pharma Mar wasn't on the list.

While Pharma Mar currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best Stocks to Own: Spring 2025 Cover

Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

SMCI’s Rally Isn’t Over – Here’s Why It Could Hit $100!
7 Flying Car Stocks to Buy Before the Sector Really Takes Off
Institutions Are Dumping These 3 Stocks—Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads